Here, we show that Orai1 plays an essential role for agonist-induced Ca2+ entry in triple negative breast cancer-derived BCSC, which is required for spheroid-forming efficiency and COX activity in these cells. The gene discussed is ORAI1; the disease is triple-negative breast carcinoma.